Compound ID | 131

Vcn-B (Vancomycin derivative)

Class: Glycopeptide

Spectrum of activity: Gram-positive
Details of activity: MRSA (methicillin resistant Staphylococcus aureus) and VRE (vancomycin resistant Enterococcus sp.)
Propensity to select resistant mutants: Yes
Institute where first reported: Cooper Group, University of Queensland, Australia
Year first mentioned: unknown
Highest developmental phase: Preclinical
Development status: Experimental

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.